Mumbai: Maharashtra Chief Minister Eknath Shinde and Deputy Chief Minister Devendra Fadnavis inaugurated Phase 2A of Mumbai Metro Line 3 on Friday, marking a significant milestone in the city’s ...

Phase 3 was launched in 2022 with a wellhead platform in 110 m of water in block 05.1Ab. PetroVietnam produced first commercial oil from the Đại Hùng oilfield Phase 3 project in Nam Con Son ...

Mumbai: Mumbai is poised to open another leg of its first underground Metro, with Phase 2 of Metro Line 3 — the Aqua Line — set to become operational from Saturday, May 10. Chief Minister ...

The Wuthering Waves 2.3 second phase banner will bring Ciaccona to the playable roster. She is confirmed to be a 5-star Aero Resonator. While Ciaccona claims to be Bard, she has picked up a Pistol ...

If you stay consistent, the results will come.' INSTRUCTIONS: Start with Phase 1 and complete Workouts 1, 2, and 3 on nonconsecutive days each week. Repeat the Phase 1 workouts until you can ...

Dive into Sprunki MSI Canon Phase 3, where new characters and immersive soundscapes deepen the narrative. Experience a thrilling evolution of dark themes. Sprunki MSI Phase 3 represents a thrilling ...

the Aqua Line (Line 3), is set to welcome commuters on its second operational stretch, Phase 2A, which connects the Bandra Kurla Complex (BKC) to Worli at Acharya Atre Chowk through a 9.77 km route, ...

The Phase 2A (Aqua Line) of Mumbai Metro Line 3 will be open to the public on Saturday, May 10. The line will run from Bandra Kurla Complex (BKC) to Worli (Acharya Atre Chowk). The 9.77-kilometer ...

The Phase 2A of Mumbai's much-awaited underground Metro Line-3 was inaugurated on Friday (May 9) by Maharashtra Chief Minister Devendra Fadnavis, connecting Bandra-Kurla Complex (BKC) to Acharya Atre ...

These version 3.3 Phase 1 Banners start on Wednesday 21st May and are expected to end on Wednesday 11th June. These version 3.3 Phase 2 Banners are expected to run from Wednesday 11th June to ...

The Phase 3 Illuccix China study [1] is a prospective, open-label, single-arm, multicenter study conducted in collaboration with Telix's strategic partner for the Greater China region, Grand ...

In 2024, Merck announced the initiation of the Phase 2/3 REJOICE-Ovarian01 trial evaluating raludotatug deruxtecan (R-DXd), an investigational potential first-in-class CDH6 directed DXd antibody ...